Gui‐Nan Lin

424 total citations
9 papers, 359 citations indexed

About

Gui‐Nan Lin is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Gui‐Nan Lin has authored 9 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Gui‐Nan Lin's work include Inflammatory Biomarkers in Disease Prognosis (4 papers), Breast Cancer Treatment Studies (2 papers) and Hepatitis B Virus Studies (2 papers). Gui‐Nan Lin is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (4 papers), Breast Cancer Treatment Studies (2 papers) and Hepatitis B Virus Studies (2 papers). Gui‐Nan Lin collaborates with scholars based in China. Gui‐Nan Lin's co-authors include Jiewen Peng, Jiewen Peng, Dongying Liu, Xiaomei Jiang, Roujun Peng, Tao Qin, Zhongyu Yuan, Shusen Wang, Jiehua He and Zhongjun Xia and has published in prestigious journals such as Tumor Biology, Medical Oncology and Asian Pacific Journal of Cancer Prevention.

In The Last Decade

Gui‐Nan Lin

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gui‐Nan Lin China 8 254 135 97 55 47 9 359
Helmut Forstbauer Germany 12 351 1.4× 158 1.2× 120 1.2× 22 0.4× 47 1.0× 53 412
Romano Scalerta Italy 9 176 0.7× 96 0.7× 72 0.7× 37 0.7× 30 0.6× 16 372
Aseem Lal United States 11 146 0.6× 61 0.5× 78 0.8× 35 0.6× 22 0.5× 17 316
Polly W.Y. Lam China 10 184 0.7× 80 0.6× 62 0.6× 83 1.5× 74 1.6× 12 385
Konstantinos Papadimitriou Greece 11 136 0.5× 39 0.3× 61 0.6× 32 0.6× 33 0.7× 22 265
Pietro Del Medico Italy 9 207 0.8× 33 0.2× 86 0.9× 16 0.3× 45 1.0× 15 420
Naohiro Nose Japan 8 219 0.9× 47 0.3× 277 2.9× 42 0.8× 19 0.4× 23 406
M.E. Fernández-Contreras Spain 12 145 0.6× 97 0.7× 26 0.3× 31 0.6× 17 0.4× 23 315
Luca Tondulli Italy 9 174 0.7× 63 0.5× 114 1.2× 18 0.3× 33 0.7× 14 285
Jian‐Guo Hong China 11 158 0.6× 49 0.4× 45 0.5× 93 1.7× 85 1.8× 30 315

Countries citing papers authored by Gui‐Nan Lin

Since Specialization
Citations

This map shows the geographic impact of Gui‐Nan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui‐Nan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui‐Nan Lin more than expected).

Fields of papers citing papers by Gui‐Nan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gui‐Nan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui‐Nan Lin. The network helps show where Gui‐Nan Lin may publish in the future.

Co-authorship network of co-authors of Gui‐Nan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Gui‐Nan Lin. A scholar is included among the top collaborators of Gui‐Nan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui‐Nan Lin. Gui‐Nan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Xu, Wei, Gui‐Nan Lin, Min Wu, et al.. (2021). Pathologic complete response after neoadjuvant tislelizumab and chemotherapy for Pancoast tumor: A case report. Thoracic Cancer. 12(8). 1256–1259. 5 indexed citations
2.
3.
Lin, Gui‐Nan, Xiaomei Jiang, Jiewen Peng, et al.. (2014). Prognostic Significance of the Peripheral Blood Absolute Monocyte Count in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma Receiving Systemic Chemotherapy. Asian Pacific Journal of Cancer Prevention. 15(15). 6387–6390. 8 indexed citations
4.
5.
6.
7.
Peng, Jiewen, et al.. (2012). Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy. Asia-Pacific Journal of Clinical Oncology. 8(4). 356–361. 34 indexed citations
8.
He, Jiehua, Roujun Peng, Zhongyu Yuan, et al.. (2011). Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray. Medical Oncology. 29(2). 406–410. 137 indexed citations
9.
Wang, Shusen, Yanxia Shi, Zhongyu Yuan, et al.. (2011). Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens. Medical Oncology. 29(2). 547–553. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helmut Forstbauer Breakdown of academic impact, for papers by Romano Scalerta Breakdown of academic impact, for papers by Aseem Lal Breakdown of academic impact, for papers by Polly W.Y. Lam Breakdown of academic impact, for papers by Konstantinos Papadimitriou Breakdown of academic impact, for papers by Pietro Del Medico Breakdown of academic impact, for papers by Naohiro Nose Breakdown of academic impact, for papers by M.E. Fernández-Contreras Breakdown of academic impact, for papers by Luca Tondulli Breakdown of academic impact, for papers by Jian‐Guo Hong
Rankless by CCL
2026